Vincerx Pharma earnings were -$27.0M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest VINC earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$7.8M, up 333.8% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, VINC reported annual earnings of -$40.2M, with -36.2% growth. The next VINC earnings date is Mar 27, 2025.
On VINC's earnings call on Invalid Date, Vincerx Pharma (NASDAQ: VINC) reported Q3 2024 earnings per share (EPS) of -$3.40, up 59.52% year over year. Total VINC earnings for the quarter were -$7.84 million. In the same quarter last year, Vincerx Pharma's earnings per share (EPS) was -$8.40.
The next VINC earnings date is Invalid Date. Add VINC to your watchlist to be reminded of Vincerx Pharma's next earnings date.
What was VINC's earnings growth in the past year?
As of Vincerx Pharma's earnings date in Invalid Date, Vincerx Pharma's earnings has grown year over year. VINC earnings in the past year totalled -$27.03 million.
Is Vincerx Pharma profitable or losing money?
As of the last Vincerx Pharma earnings report, Vincerx Pharma is currently losing money. Vincerx Pharma's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$27.03 million, a 41.83% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.